612
Views
7
CrossRef citations to date
0
Altmetric
Drug Evaluations

Bortezomib for previously untreated multiple myeloma

, MD PhD
Pages 2553-2564 | Published online: 23 Sep 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Prithviraj Bose, Michael S Batalo, Beata Holkova & Steven Grant. (2014) Bortezomib for the treatment of non-Hodgkin’s lymphoma. Expert Opinion on Pharmacotherapy 15:16, pages 2443-2459.
Read now

Articles from other publishers (6)

Antonio Di Dato, Alessandra Cunsolo, Marco Persico, Anna Maria Santoro, Alessandro D’Urso, Danilo Milardi, Roberto Purrello, Manuela Stefanelli, Roberto Paolesse, Grazia R. Tundo, Diego Sbardella, Caterina Fattorusso & Massimo Coletta. (2017) Electrostatic Map Of Proteasome α-Rings Encodes The Design of Allosteric Porphyrin-Based Inhibitors Able To Affect 20S Conformation By Cooperative Binding. Scientific Reports 7:1.
Crossref
Anna Maria Santoro, Irene Monaco, Francesco Attanasio, Valeria Lanza, Giuseppe Pappalardo, Marianna Flora Tomasello, Alessandra Cunsolo, Enrico Rizzarelli, Ada De Luigi, Mario Salmona & Danilo Milardi. (2016) Copper(II) ions affect the gating dynamics of the 20S proteasome: a molecular and in cell study. Scientific Reports 6:1.
Crossref
Isao Momose, Hikaru Abe, Takumi Watanabe, Shun‐ichi Ohba, Kanami Yamazaki, Shingo Dan, Takao Yamori, Tohru Masuda & Akio Nomoto. (2014) Antitumor effects of tyropeptin‐boronic acid derivatives: New proteasome inhibitors. Cancer Science 105:12, pages 1609-1615.
Crossref
Paul M. Neilsen, Ashok D. Pehere, Kathleen I. Pishas, David F. Callen & Andrew D. Abell. (2012) New 26S Proteasome Inhibitors with High Selectivity for Chymotrypsin-Like Activity and p53-Dependent Cytotoxicity. ACS Chemical Biology 8:2, pages 353-359.
Crossref
CHUANYING GENG, NIAN LIU, GUANGZHONG YANG, AIJUN LIU, YUN LENG, HUIJUAN WANG, LIHONG LI, YIN WU, YANCHEN LI & WENMING CHEN. (2013) Retrospective analysis of 264 multiple myeloma patients. Oncology Letters 5:2, pages 707-713.
Crossref
Rajesh R. Nair, Anthony W. Gebhard, Michael F. Emmons & Lori A. Hazlehurst. 2012. Current Challenges in Personalized Cancer Medicine. Current Challenges in Personalized Cancer Medicine 143 189 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.